Literature DB >> 18568040

Ras oncogenes: split personalities.

Antoine E Karnoub1, Robert A Weinberg.   

Abstract

Extensive research on the Ras proteins and their functions in cell physiology over the past 30 years has led to numerous insights that have revealed the involvement of Ras not only in tumorigenesis but also in many developmental disorders. Despite great strides in our understanding of the molecular and cellular mechanisms of action of the Ras proteins, the expanding roster of their downstream effectors and the complexity of the signalling cascades that they regulate indicate that much remains to be learnt.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18568040      PMCID: PMC3915522          DOI: 10.1038/nrm2438

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN: 1471-0072            Impact factor:   94.444


  230 in total

1.  Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras.

Authors:  N W Gale; S Kaplan; E J Lowenstein; J Schlessinger; D Bar-Sagi
Journal:  Nature       Date:  1993-05-06       Impact factor: 49.962

2.  Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1.

Authors:  X F Zhang; J Settleman; J M Kyriakis; E Takeuchi-Suzuki; S J Elledge; M S Marshall; J T Bruder; U R Rapp; J Avruch
Journal:  Nature       Date:  1993-07-22       Impact factor: 49.962

3.  Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue.

Authors:  D J Capon; E Y Chen; A D Levinson; P H Seeburg; D V Goeddel
Journal:  Nature       Date:  1983-03-03       Impact factor: 49.962

4.  Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor.

Authors:  L Buday; J Downward
Journal:  Cell       Date:  1993-05-07       Impact factor: 41.582

5.  Ha-ras oncogenes are activated by somatic alterations in human urinary tract tumours.

Authors:  J Fujita; O Yoshida; Y Yuasa; J S Rhim; M Hatanaka; S A Aaronson
Journal:  Nature       Date:  1984 May 31-Jun 6       Impact factor: 49.962

6.  Isolation of transforming sequences of two human lung carcinomas: structural and functional analysis of the activated c-K-ras oncogenes.

Authors:  H Nakano; F Yamamoto; C Neville; D Evans; T Mizuno; M Perucho
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

7.  Epidermal growth factor stimulates guanine nucleotide binding activity and phosphorylation of ras oncogene proteins.

Authors:  T Kamata; J R Feramisco
Journal:  Nature       Date:  1984 Jul 12-18       Impact factor: 49.962

8.  Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient.

Authors:  E Santos; D Martin-Zanca; E P Reddy; M A Pierotti; G Della Porta; M Barbacid
Journal:  Science       Date:  1984-02-17       Impact factor: 47.728

9.  Mouse cells contain two distinct ras gene mRNA species that can be translated into a p21 onc protein.

Authors:  R W Ellis; D DeFeo; M E Furth; E M Scolnick
Journal:  Mol Cell Biol       Date:  1982-11       Impact factor: 4.272

10.  Complexes of Ras.GTP with Raf-1 and mitogen-activated protein kinase kinase.

Authors:  S A Moodie; B M Willumsen; M J Weber; A Wolfman
Journal:  Science       Date:  1993-06-11       Impact factor: 47.728

View more
  609 in total

1.  Molecular characteristics of Clostridium perfringens TpeL toxin and consequences of mono-O-GlcNAcylation of Ras in living cells.

Authors:  Gregor Guttenberg; Sven Hornei; Thomas Jank; Carsten Schwan; Wei Lü; Oliver Einsle; Panagiotis Papatheodorou; Klaus Aktories
Journal:  J Biol Chem       Date:  2012-06-04       Impact factor: 5.157

2.  Inhibiting the palmitoylation/depalmitoylation cycle selectively reduces the growth of hematopoietic cells expressing oncogenic Nras.

Authors:  Jin Xu; Christian Hedberg; Frank J Dekker; Qing Li; Kevin M Haigis; Eugene Hwang; Herbert Waldmann; Kevin Shannon
Journal:  Blood       Date:  2011-12-05       Impact factor: 22.113

3.  PINCH1 regulates Akt1 activation and enhances radioresistance by inhibiting PP1alpha.

Authors:  Iris Eke; Ulrike Koch; Stephanie Hehlgans; Veit Sandfort; Fabio Stanchi; Daniel Zips; Michael Baumann; Anna Shevchenko; Christian Pilarsky; Michael Haase; Gustavo B Baretton; Véronique Calleja; Banafshé Larijani; Reinhard Fässler; Nils Cordes
Journal:  J Clin Invest       Date:  2010-06-07       Impact factor: 14.808

4.  Characterization of KRAS rearrangements in metastatic prostate cancer.

Authors:  Xiao-Song Wang; Sunita Shankar; Saravana M Dhanasekaran; Bushra Ateeq; Atsuo T Sasaki; Xiaojun Jing; Daniel Robinson; Qi Cao; John R Prensner; Anastasia K Yocum; Rui Wang; Daniel F Fries; Bo Han; Irfan A Asangani; Xuhong Cao; Yong Li; Gilbert S Omenn; Dorothee Pflueger; Anuradha Gopalan; Victor E Reuter; Emily Rose Kahoud; Lewis C Cantley; Mark A Rubin; Nallasivam Palanisamy; Sooryanarayana Varambally; Arul M Chinnaiyan
Journal:  Cancer Discov       Date:  2011-06-01       Impact factor: 39.397

5.  c-Myc regulates RNA splicing of the A-Raf kinase and its activation of the ERK pathway.

Authors:  Jens Rauch; Kim Moran-Jones; Valerie Albrecht; Thomas Schwarzl; Keith Hunter; Olivier Gires; Walter Kolch
Journal:  Cancer Res       Date:  2011-04-21       Impact factor: 12.701

6.  c-Raf, but not B-Raf, is essential for development of K-Ras oncogene-driven non-small cell lung carcinoma.

Authors:  Rafael B Blasco; Sarah Francoz; David Santamaría; Marta Cañamero; Pierre Dubus; Jean Charron; Manuela Baccarini; Mariano Barbacid
Journal:  Cancer Cell       Date:  2011-04-21       Impact factor: 31.743

7.  WT1: a weak spot in KRAS-induced transformation.

Authors:  Silvia Licciulli; Joseph L Kissil
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

8.  MELK Promotes Melanoma Growth by Stimulating the NF-κB Pathway.

Authors:  Radoslav Janostiak; Navin Rauniyar; TuKiet T Lam; Jianhong Ou; Lihua J Zhu; Michael R Green; Narendra Wajapeyee
Journal:  Cell Rep       Date:  2017-12-05       Impact factor: 9.423

9.  A novel terpenoid class for prevention and treatment of KRAS-driven cancers: Comprehensive analysis using in situ, in vitro, and in vivo model systems.

Authors:  Arsheed A Ganaie; Hifzur R Siddique; Ishfaq A Sheikh; Aijaz Parray; Lei Wang; Jayanth Panyam; Peter W Villalta; Yibin Deng; Badrinath R Konety; Mohammad Saleem
Journal:  Mol Carcinog       Date:  2020-04-15       Impact factor: 4.784

10.  R-Ras1 and R-Ras2 Are Essential for Oligodendrocyte Differentiation and Survival for Correct Myelination in the Central Nervous System.

Authors:  Miriam Sanz-Rodriguez; Agnès Gruart; Juan Escudero-Ramirez; Fernando de Castro; José María Delgado-García; Francisco Wandosell; Beatriz Cubelos
Journal:  J Neurosci       Date:  2018-05-02       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.